GlassScriptPhysician profile
Jennifer Harrison
NPI 1497397558
$1,409.10
in general payments reported to CMS, 2019-2025
14 companies · $136 in 2025
The $136 reported for 2025 was more than what a typical Critical Care Medicine (Nurse Practitioner) provider received nationally (typical 2025 total: $118).
See the full distribution for Critical Care Medicine (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $500 · 2022: $388 · 2023: $161 · 2024: $224 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $348.98 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $260.40 | 2021-2024 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $225.35 | 2021-2022 | |
| Abiomed | $143.04 | 2024 | Impella |
| Solventum Corporation | $121.08 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Astrazeneca Pharmaceuticals LP | $80.08 | 2021-2022 | |
| Pfizer INC. | $53.42 | 2021-2022 | |
| Irhythm Technologies, INC. | $38.79 | 2024 | Zio Xt Patch, Zio Monitor |
| Cvrx, INC. | $34.46 | 2022 | |
| Esperion Therapeutics, INC. | $30.19 | 2021 | |
| Novartis Pharmaceuticals Corporation | $29.92 | 2023 | |
| Atricure, INC. | $15.18 | 2025 | Synergy Ablation System |
| Amgen INC. | $15.17 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.